RRML - Associations of pathogenic mutations responsible for breast cancer risk with histology and immunohistochemistry in Romanian population

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2016): 55%

Română English

SCImago Journal & Country Rank

Advanced search

Top 10 downloaded articles
- February 2018 -
Innate Immune Mechanisms in Myoca... 19
Diagnostic accuracy of red blood ... 18
Ischemic modified albumin increas... 17
Spontaneous atrial fibrillation a... 17
Plasma phosphorylated neurofilame... 14
The impact of immunological and b... 12
Associations of pathogenic mutati... 11
CXCL13 levels are more increased ... 10
The frequency of Human Papillomav... 10
Thrombophilia genetic testing in ... 9

Log in

Concept, Design & Programming
Dr. Adrian Man

Ahead of print DOI:10.1515/rrlm-2017-0037

Research article

Associations of pathogenic mutations responsible for breast cancer risk with histology and immunohistochemistry in Romanian population

Iulian Gabriel Goidescu, Dan Tudor Eniu, Gabriela Valentina Caracostea, Gheorghe Cruciat, Florin Stamatian

Correspondence should be addressed to: Dan Tudor Eniu


Introduction: Breast cancer is the most common cancer in women worldwide, and Romania makes no exception from this trend. Genetic screening for Hereditary Breast and Ovarian Cancer began to be used on a larger scale after the introduction of Next Generation Sequencing. The aim of this study was to assess the association of deleterious mutations responsible for breast cancer with histopathological and immunohistochemical prognostic factors and to identify some genetic variants in the BRCA1 and BRCA2 genes. Method: 80 patients with breast cancer and negative genetic test or pathogenic variants on BRCA1/2, TP53, PALB2, CHEK2, ATM genes were included. All the cases had a prior histological diagnosis and complete immunohistochemical features. The genetic testing was conducted through a multigene panel. Results: 65% of patients had a deleterious mutation on BRCA genes. In 97.5% of cases the histology was invasive ductal carcinoma. Significant differences were identified between BRCA1 group and negative mutation group regarding estrogen receptor (ER) (p=0.0051), progesterone receptor (PR) (p=0.0004) and Ki67 (p=0.001). Seven breast cancer patients had BRCA1 c.3607C>T variant, which was statistically significantly associated with triple- negative breast cancer (p <0.0001). Of the 7 cases diagnosed with BRCA 2 mutations we identified the c.8755-1G>A variant in 3 cases and the c.9371A>T variant in 3 cases. Discussion and conclusion: Our study confirmed the association of BRCA1 mutations with negative ER, PR or triple negative breast cancer (TNBC). Description of BRCA1 c.3607C>T mutation for the first time in Romanian population and its association with TNBC will need further investigation.

Keywords: pathogenic variants, hereditary breast and ovarian cancer syndrome, breast cancer, triple-negative breast cancer

Received: 25.9.2017
Accepted: 4.12.2017
Published: 5.1.2018

  PDF Download full text PDF
(543 KB)